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Abstract 
Background: Rab5 GTPase regulates membrane trafficking between the plasma membrane and endosomes and 
harbours a conserved C‑terminal isoprenyl modification that is necessary for membrane recruitment. Plasmodium 
falciparum encodes three Rab5 isotypes, and one of these, Rab5b (PfRab5b), lacks the C‑terminal modification but 
possesses the N‑terminal myristoylation motif. PfRab5b was reported to localize to the parasite periphery. However, 
the trafficking pathway regulated by PfRab5b is unknown.
Methods: A complementation analysis of Rab5 isotypes was performed in Plasmodium berghei. A constitutively 
active PfRab5b mutant was expressed under the regulation of a ligand‑dependent destabilization domain (DD)‑tag 
system in P. falciparum. The localization of PfRab5b was evaluated after removing the ligand followed by selective 
permeabilization of the membrane with different detergents. Furthermore, P. falciparum N‑terminally myristoylated 
adenylate kinase 2 (PfAK2) was co‑expressed with PfRab5b, and trafficking of PfAK2 to the parasitophorous vacuole 
membrane was examined by confocal microscopy.
Results: PfRab5b complemented the function of PbRab5b, however, the conventional C‑terminally isoprenylated 
Rab5, PbRab5a or PbRab5c, did not. The constitutively active PfRab5b mutant localized to the cytosol of the parasite 
and the tubovesicular network (TVN), a region that extends from the parasitophorous vacuole membrane (PVM) 
in infected red blood cells (iRBCs). By removing the DD‑ligand, parasite cytosolic PfRab5b signal disappeared and a 
punctate structure adjacent to the endoplasmic reticulum (ER) and parasite periphery accumulated. The peripheral 
PfRab5b was sensitive to extracellular proteolysis after treatment with streptolysin O, which selectively permeabilizes 
the red blood cell plasma membrane, indicating that PfRab5b localized on the iRBC cytoplasmic face of the TVN. 
Transport of PfAK2 to the PVM was abrogated by overexpression of PfRab5b, and PfAK2 accumulated in the punctate 
structure together with PfRab5b.
Conclusion: N‑myristoylated Plasmodium Rab5b plays a role that is distinct from that of conventional mammalian 
Rab5 isotypes. PfRab5b localizes to a compartment close to the ER, translocated to the lumen of the organelle, and 
co‑localizes with PfAK2. PfRab5b and PfAK2 are then transported to the TVN, and PfRab5b localizes on the iRBC cyto‑
plasmic face of TVN. These data demonstrate that PfRab5b is transported from the parasite cytosol to TVN together 
with N‑myristoylated PfAK2 via an uncharacterized membrane‑trafficking pathway.
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Background
Intracellular malaria parasites secrete hundreds of pro-
teins into their host red blood cell (RBC) cytoplasm, 
which is necessary for host cell modification and intracel-
lular survival. Many of these exported proteins contain an 
endoplasmic reticulum (ER) signal sequence and a short 
pentameric motif called a Plasmodium export element 
(PEXEL) [1]. PEXEL motif-containing proteins are trans-
ported through the vesicular transport pathway [2, 3], 
and might be recognized by a translocon complex located 
on the parasitophorous vacuole membrane (PVM), Plas-
modium translocon of exported proteins (PTEX), for 
the translocation of PEXEL proteins to the cytoplasm of 
infected red blood cells (iRBCs) [4, 5]. Although translo-
cation of exported proteins that lack a canonical PEXEL 
motif is also mediated by PTEX, the trafficking mecha-
nism of PEXEL-negative proteins has not been fully elu-
cidated [1, 5].
A membranous extension from the PVM forms a cyto-
plasmic tubovesicular network (TVN) [6, 7]. TVN can be 
stained by fluorescent ceramide and have sphingomyelin 
synthase activity [8]. In addition, a substrate analogue of 
sphingomyelin synthase inhibits TVN formation and the 
uptake of nutrients by the parasite [9, 10]. Thus, TVN 
has been proposed to be a part of sphingolipid-rich rafts 
and related to nutrient uptake. Several transmembrane 
proteins and membrane-associated proteins that are 
post-translationally modified with saturated fatty acids 
in a process referred to as ‘acylation’ are recruited to the 
membrane raft domain [11]. Indeed, Plasmodium falci-
parum adenylate kinase 2 (PfAK2), which is modified by 
two N-terminal acylation sites, i.e., myristoylation and 
palmitoylation, localizes to the TVN-like membrane pro-
trusion of the PVM [12]. Transport of PfAK2 to the TVN 
is dependent on its myristoylation and palmitoylation 
[13], indicating that lipid acylation might be an alterna-
tive protein secretion signal to and from the PVM. How-
ever, the mechanism of the transport of acylated proteins 
to iRBC cytoplasm is not clearly understood.
In eukaryotic membrane trafficking, specific mem-
brane fusions and cargo protein sorting are regulated 
by the Rab family of small guanosine-5′-triphosphatases 
(GTPases) [14–16]. In conventional Rab GTPases, the 
isoprenylation of a highly conserved cysteine motif 
in the carboxyl terminus (C-terminus) is essential for 
membrane recruitment of Rab [15, 16]. Rab GTPases 
cycle between two distinct states, a GTP-bound mem-
brane-associated active form and a GDP-bound mainly 
cytosolic inactive form. A constitutively active mutant, 
which was created by the introduction of a specific 
amino acid substitution in the conserved GTP-bind-
ing motif, shows reduced GTPase activity [17, 18]. This 
active mutant stimulates recruitment of specific binding 
partners on target membrane, and then activates vesicle 
transport, tethering and fusion [15]. Thus, expression of 
constitutively active mutant of mammalian Rab5 or Rab8 
causes promoting excessive membrane fusion [18, 19]. 
In case of mammalian Rab6 and yeast Sec4, for which 
GTPase activity is necessary for completion of their roles, 
inhibitory effect on membrane fusion is reported [20, 21]. 
Analyses using an active mutant of Rab provide critical 
information of its function and subcellular localization in 
many organisms.
Eleven Rab genes are found in the Plasmodium 
genome [22] and functions have been reported for sev-
eral members. Plasmodium Rab6 and Rab7 are involved 
in the trafficking from the Golgi and in the endosomal 
pathways, respectively, during the asexual develop-
ment in its life cycle [23, 24]. PfRab11a is involved in 
the post-Golgi trafficking to the invaginated plasma 
membrane during the daughter merozoite biogen-
esis in late-stage schizonts [25]. Interestingly, among 
three Plasmodium Rab5 homologues, a conventional 
Rab5 homologue, PfRab5a, is involved in the haemo-
globin uptake at the plasma membrane and the trans-
port to the food vacuole [26]. In contrast, N-terminally 
myristoylated PfRab5b that lacks a C-terminal cysteine 
residue localizes to the parasite food vacuole and the 
plasma membrane [27], indicating functional diversi-
fication of Rab5 subfamily members in Plasmodium. 
Apart from this, intracellular malaria parasites secrete 
hundreds of proteins into the host RBC cytoplasm 
for which vesicular trafficking is also proposed to be 
involved. However, very little is known about the role 
of Rab GTPases in this process.
Functional difference between conventional, C-termi-
nally isoprenylated Rab5 and N-terminally myristoylated 
Rab5 have been reported in higher plants [28]. Conven-
tional Rab5 regulates endocytic transport in other organ-
isms [29] and also in higher plants [30, 31]. In contrast, 
Arabidopsis thaliana N-terminally myristoylated Rab5 
isotype, namely ARA6/RabF1, regulates the transport 
from the endosome to the plasma membrane [28, 32, 33]. 
N-terminal myristoylation and palmitoylation are essen-
tial for endosome targeting and the function of ARA6/
RabF1 [28, 32, 33]. Proteins similar to ARA6/RabF1 
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are highly conserved among higher plants and regulate 
plant-specific trafficking pathways [34, 35].
In the present study, the mechanism of N-myris-
toylated Rab5b-dependent membrane trafficking in Plas-
modium was clarified. The loss of function of Rab5b was 
not complemented by other conventional Rab5 isotypes, 
Rab5a and Rab5c, in Plasmodium berghei. In addition, 
the constitutively active mutant Rab5b in P. falciparum, 
which was expressed under the inducible destabilization 
domain (DD) system, localized on the iRBC cytoplasmic 
face of the PVM and the TVM. Furthermore, PfRab5b 
over-expression prevented the localization of N-acylated 
PfAK2 on the PVM, and N-acylated PfAK2 was accumu-
lated in the parasite cytosol. This is the first study to show 
that two N-acylated proteins, PfRab5b and PfAK2, share 
the same trafficking pathway to PVM in Plasmodium.
Methods
Ethics statement
All animal procedures were approved by the Institutional 
Animal Care and Use Committee (No. 212010-2, 213013-
2) and conducted at the AAALAC-accredited National 
Institute of Infectious Diseases, Japan. Human RBCs and 
plasma were obtained as donations from anonymized 
individuals at the Japanese Red Cross Society (No. 
25J0022).
Strains and transfection protocols
Plasmodium berghei ANKA strain (clone 2.34), contrib-
uted by TF McCutchan, was obtained from the Malaria 
Research and Reference Reagent Resource Center (MR4). 
Transfection and pyrimethamine selection was per-
formed as described previously [36]. Genomic integra-
tion of the plasmid was assessed by polymerase chain 
reaction (PCR). A complementation assay was performed 
whether transformed parasites were selected with 
pyrimethamine after 3 weeks. If a transformant parasite 
was selected within 3  weeks, genome integration of the 
plasmid into the PbRab5b locus was assessed by PCR. A 
strain that expressed PbRab5b-monomeric Azami Green 
(mAG) (Medical Biological Laboratories) was cloned 
by limiting-dilution. For analysing parasite growth, 
104 parasites were intravenously injected into 5-weeks 
old BALB/c female mice. Plasmodium falciparum line 
MS822 [37] was cultured as described previously [38], 
and transfection of P. falciparum was performed accord-
ing to the published method [38, 39]. Briefly, uninfected 
RBCs were suspended in 400  μl of cytomix containing 
100 μg of plasmid DNA. Electroporation was performed 
in 0.2  cm cuvettes using the BTX Electroporation Sys-
tem (condition: 0.32  kV, 950 μF; Harvard Apparatus, 
MA, USA). Transfected RBCs were mixed with tropho-
zoite-rich parasite culture at a final concentration of 
0.1 % parasitemia. At 3 days post transfection, transfect-
ants were selected with 5 nM WR99210-HCl (a kind gift 
from D Jacobus) or 2.5 μg/ml of blasticidin S-HCl (BSD; 
Sigma-Aldrich). Resistant parasites were usually detected 
before 1 month of culture in the presence of drugs.
Plasmid construction
pL0006 was obtained from MR4 (deposited by AP 
Waters) and was used to make a panel of transfection 
constructs. To replace the genomic sequence encod-
ing PbRab5b, 500  bp upstream and downstream of the 
PbRab5b locus were cloned into HindIII–PstI and XhoI–
EcoRI sites of pL0006, respectively (PbRab5b-KO plas-
mid). A series of open reading frames (ORFs) comprising 
the sequences encoding PbRab5b, mAG, and the termi-
nator region of P. berghei dihydrofolate reductase (PbDT) 
were PCR-amplified with overlapping oligonucleotides 
and were then inserted into the PstI site of the PbRab5b-
KO plasmid using an In Fusion HD cloning kit (Clontech, 
USA) to yield PbRab5b-mAG plasmid. For complemen-
tation analysis, each gene-of-interest (GOI) was PCR-
amplified, and an In Fusion HD cloning kit was used to 
replace the PbRab5b ORF in the PbRab5b-mAG plasmid.
To construct a plasmid expressing PfRab5b-YFP-DD, 
a fusion fragment comprising P. falciparum chloro-
quine resistance transporter (CRT) promoter, PfRab5b 
coding region, yellow fluorescent protein (YFP; from 
D E Goldberg) and DD domain optimized for C-termi-
nal fusion (Clontech) was PCR-amplified and inserted 
between attR4 and attR3 sites of pCHD43(II) [40] to 
yield PfRab5b-YFP-DD plasmid. To construct a plasmid 
that expresses a RFP-fusion protein, a PfRab5b-YFP-DD 
fragment and a human dihydrofolate reductase (DHFR) 
cassette in the PfRab5b-YFP-DD plasmid were replaced 
with a TagRFP fragment and a BSD-resistance cassette 
amplified from pLN-ENR-GFP (MR4, deposited by DA 
Fidock), respectively. PfAK2, PfSec13, PfVPS2, and the 
apicoplast-targeting signal sequences [41] were PCR-
amplified and inserted into the downstream of the CRT 
promoter in the RFP plasmid. To express the N-termi-
nal 20 amino acids (aa) of PfRab5b fused to YFP-DD, a 
sequence containing 61–624  bp of the PfRab5b coding 
region was removed from the PfRab5b-YFP-DD plas-
mid. In Fusion HD Cloning kit was used to construct all 
plasmids.
Schematic structures of plasmids are shown in Addi-
tional file 1, and all primers are listed in Additional file 2: 
Table S1 with their sequence.
Antibodies
Anti-PfTPx-1 and anti-PfTPx-2 were gifts from S-I 
Kawazu (Obihiro University of Agriculture and Veteri-
nary Medicine) [42, 43]; anti-PfSBP-1 and anti-PfEXP-2 
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were from T Tsuboi (Ehime University) [44]; and anti-
PfBip was from K Kita (University of Tokyo). Rabbit anti-
PfEVP1 and anti-PfERD2 antibodies were raised against 
the previously reported peptides LKFQHDQEFLNY-
FKRYQDFN and CYFALAKWYGKKLVLPFNGEV [45, 
46], respectively, by Operon Biotechnologies (Tokyo, 
Japan). Anti-GFP antibodies, purchased from Molecular 
Probes (rabbit anti-GFP antibody, A11122) and Roche 
(anti-GFP mouse antibody, 11814460001), were used for 
the indirect immunofluorescence assay and immunob-
lots to probe YFP, respectively. Antibodies were used for 
immunoblotting at the following dilutions; anti-PfEXP2 
(1:8,000), anti-PfTPx-1 (1:1,000), anti-PfSBP-1 (1:10,000) 
and anti-GFP (1:100).
Confocal microscopy
Immunofluorescence assays were performed with the 
antibodies incubated at the following dilutions; anti-
PfTPx-1 (1:200), anti-PfTPx-2 (1:200), anti-PfERD2 
(1:100), anti-PfBip (1:200), anti-PfSBP1 (1:5,000), anti-
PfEVP1 (1:50), anti-PfEXP2 (1:200), and anti-GFP 
(1:100). Alexa 488- and Alexa 568-conjugated anti-
rabbit IgG, and Alexa 568-conjugated anti-mouse IgG 
(Molecular Probes) were used as secondary antibodies. 
Images were acquired using a LSM510 or LSM780 con-
focal laser-scanning microscope (Zeiss, Germany). To 
visualize TVN membranes, iRBCs were incubated with 
2.5  µM BODIPY Texas Red C5-ceramide ((N-((4-(4,4-
difluoro-5-(2-thienyl)-4-bora-3a,4a-diaza-s-indacene-
3-yl)phenoxy)-acetyl)sphingosine, Molecular Probes) for 
1–2  h. Samples were washed with RPMI 1640 medium, 
and the YFP and TR-ceramide fluorescence were cap-
tured using an LSM 7-Live laser-scanning microscope 
(Zeiss).
Induction and Shld1 washout assay
For the regulated induction of PfRab5b-YFP, parasites 
transfected with DD-based plasmids were incubated with 
0.5  μM Shld1 (Clontech) for the indicated times. After 
incubation, iRBCs were washed twice with Shld1-free 
medium, then further incubated with Shld1-free medium 
for 1 h (Fig. 5) or 2 h (others). Samples were then stained 
with TR-ceramide for 30 min, and images were acquired 
using an LSM 7-Live laser-scanning microscope.
Antibody accessibility assay
iRBCs (1–5 % parasitaemia) were incubated with 0.5 μM 
Shld1, fixed with 4  % paraformaldehyde in phosphate-
buffered saline (PFA-PBS) at 4 °C for 18 h, and permeabi-
lized with 0.01 % saponin-PBS or 0.1 % Triton X-100-PBS 
for 1  h. Samples were incubated with rabbit anti-GFP 
antibody and Alexa 568-conjugated anti-rabbit IgG anti-
body (Molecular Probes).
Proteinase K accessibility assay
The accessibility by proteinase K was determined as 
reported previously with some modifications [47]. 
Briefly, a 5-ml culture of iRBCs (1–5  % parasitaemia) 
was incubated with 0.5 μM of Shld1 for 24 h, then fur-
ther incubated with a Shld1-free medium for 2.5  h. 
RBCs were collected by centrifugation at 500×g for 
5 min and permeabilized with 500 μl of streptolysin O 
(SLO) solution (2.5 U/ml SLO in PBS) for 30 min. After 
SLO treatment, samples were washed twice with 5  ml 
of PBS, resuspended to 80  µl with PBS, and then ali-
quoted into two tubes containing 40  µl of each solu-
tion. Proteinase K solution (1  µl, 18  mg/ml, Roche 
11389200) was added to one tube, and both tubes were 
incubated on ice for 30 min. Phenylmethylsulfonyl fluo-
ride (PMSF) (5 µl, 200 mM) was added to each sample, 
followed by 25  µl of 3  ×  SDS-PAGE buffer, and then 
samples were incubated at 95  °C for 5  min. Fifteen-
microliter samples were loaded into each well of the 
SDS-PAGE gels.
Results
The entire Rab5b GTPase domain is required for the 
growth of asexual blood stage of Plasmodium berghei
Recent attempts to generate a deletion mutant of N-ter-
minally myristoylated and palmitoylated Rab5b in the 
rodent malaria parasite P. berghei (PBANKA_140910) 
were unsuccessful, suggesting that PbRab5b is essential 
(See figure on next page.) 
Fig. 1 Complementation of Plasmodium berghei N‑acylated Rab5b with conventional Rab5 and Rab5b from other apicomplexan parasites. a 
Schematic representation of PbRab5b genomic‑locus replacement strategy. The targeting construct, consisting of the 5′ and 3′ regions (two black 
boxes) and PbRab5b open reading frame (ORF) (orange) fused to mAG (dark green), P. berghei DHFR 3′ untranslated region (PbDT) (blue), and the 
selectable marker TgDHFR expression cassette (white), was integrated into the PbRab5b genomic locus (orange) by double‑crossover homologous 
recombination. The positions of the four PCR primers used to confirm the plasmid integration (right panel) are indicated. b Growth curve of the wild‑
type parasites (blue) and transgenic parasites for which the PbRab5b open reading frame replaced with PbRab5b‑mAG (red). Bars standard deviation 
(n = 5). c Multiple amino acid sequence alignment of Plasmodium Rab5 isoforms. The GTP‑binding consensus sequences and lipid modification sites 
are indicated red and blue boxes, respectively. The effector regions are shown as grey, black or magenta boxes. The conserved glutamine residue which 
was mutated to create a constitutively active mutant is shown in a red arrow. d Complementation test of the PbRab5b knockout. The coding region 
of PbRab5b was replaced with each gene‑of‑interest (GOI). The result of the complementation analysis is shown at the right; +, complemented or −, 
uncomplemented (n = 3)
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for the asexual blood stage of the parasite [27]. To fur-
ther explore the conserved function of Rab5b in apicom-
plexan parasites, the endogenous PbRab5b locus was 
replaced with following Rab5 homologues; Rab5b 
from human malaria pathogen P. falciparum (PfRab5b, 
PF3D7_1310600), Rab5b from the distantly-related 
apicomplexan parasite Toxoplasma gondii (TgRab5b, 
TGME49_207460), and the other conventional Rab5 
isoforms of P. berghei (PbRab5a, PBANKA_030800 and 
PbRab5c PBANKA_020650) (Fig. 1).
First, the genomic locus encoding PbRab5b was 
replaced with a fragment encoding PbRab5b fused to 
monomeric Azami Green (mAG) (Fig.  1a). This trans-
genic parasite grew as well as the wild type (Fig.  1b), 
indicating that the PbRab5b-mAG fusion protein 
was functional. The PbRab5b genomic locus was also 
successfully replaced with PfRab5b fused to mAG 
(PfRab5b-mAG), indicating that PfRab5b comple-
mented the function of PbRab5b (Fig. 1c, d). This result 
is supported by the presence of a completely conserved 
effector sequence (HQVTIGAAFL) between PbRab5b 
[amino acid residues (aa) 60–69] and PfRab5b (aa 
63–72) that specifies the function of Rab proteins [48, 
49] (Fig.  1c). In contrast, P. berghei-transfected with 
TgRab5b-mAG, which has a similar effector sequence 
(aa 66–75, HEVTIGAAFL, with the underline indi-
cating different residue) in addition to a characteristic 
insertion sequence (aa 165–178, Additional file  3), did 
not functionally complement PbRab5b (Fig.  1d). These 
results suggest that the molecular function of Rab5b in 
P. berghei is conserved with P. falciparum, but not with 
Toxoplasma gondii.
After drug selection, parasites transfected with plas-
mids replacing PbRab5b with conventional Rab5 iso-
forms, PbRab5a and PbRab5c, were not obtained, 
suggesting Rab5a and Rab5c were unable to complement 
endogenous PbRab5b (Fig. 1d). To identify the functional 
regions of PbRab5b, a panel of chimeric constructs, 
which consisted of PbRab5b with replacements of equiv-
alent regions of PbRab5a or PbRab5c, was expressed. 
The following chimeric constructs did not comple-
ment endogenous PbRab5b; aa 1–34, 1–69, or 1–92 in 
PbRab5b-mAG proteins were replaced with equivalent 
regions from PbRab5a (Fig. 1d, PbRab5b–5a #1, #2, and 
#3, respectively), and aa 1–69 in PbRab5b-mAG was 
replaced with corresponding sites of PbRab5c (Fig.  1d, 
PbRab5b–5c). The only chimera that complemented the 
PbRab5b locus was a construct that included the entire 
GTPase motif of Rab5b (aa 1–192, PbRab5b–5a #4). 
These results indicate that PbRab5b functions differently 
from PbRab5a or PbRab5c, and that the GTPase activity 
is required for a proper Rab5b function.
Localization of the constitutively active PfRab5bQ94L 
mutant in the TVN
Expression of the constitutively active mutant of Rab5 
GTPases in mammalian cells, which were recruited to 
the membrane and accumulated on the target organelle, 
allows insights into the function and subcellular localiza-
tion of the transport pathway [18, 50]. In this study, the 
traffic pathway regulated by Plasmodium Rab5b using 
a constitutively active Plasmodium Rab5 mutant was 
investigated.
At the schizont stage, wild-type PfRab5b localizes 
near the parasite plasma membrane [27]. The PbRab5b-
mAG expressed in the parasite showed a cytosolic pat-
tern (Additional file  4a) over a slightly larger area than 
the cytosolic marker at the trophozoite stage (Addi-
tional file  4b). The constitutively active PbRab5bQ91L-
mAG mutant (Fig.  1c) accumulated at the periphery of 
the parasite (Additional file 4c). However, because of the 
low level of PbRab5b-mAG signal, the precise location of 
PbRab5b was difficult to determine based on this image.
To examine whether Rab5b was transported to the 
parasite plasma membrane and then secreted to the PV 
space, the DD-fused constitutively active PfRab5bQ94L 
mutant (Fig. 1c) was expressed in P. falciparum [51, 52]. 
In Toxoplasma, over-expression of wild-type TgRab5b 
under the regulation of a DD-tag inhibits egress of 
daughter tachyzoites from host cells [53]. In contrast, 
neither PfRab5b-YFP-DD nor PfRab5bQ94L-YFP-DD 
expression altered parasite growth with 2 or 3  days of 
incubation with Shld1, whereas PfRab5b-YFP-DD pro-
tein expression had already plateaued after the 24  h of 
incubation with Shld1 (Additional file 5), indicating that 
over-expression of the wild type or constitutively active 
mutant of PfRab5b did not affect the parasite growth. 
Another Rab mutant, nucleotide-free PfRab5bN148I 
mutant, was not successfully expressed by the DD-tag 
system, thus PfRab5b-YFP-DD and PfRab5bQ94L-YFP-DD 
parasites were used in this analysis.
First, constitutively active PfRab5bQ94L-expressing par-
asites were double-stained with fluorescent TR-ceramide, 
which allowed visualization of the PVM and TVN [45]. 
The PfRab5bQ94L-YFP-DD signal was co-localized with 
TR-ceramide-positive TVN structures after 24 h of incu-
bation with Shld1 (Fig. 2a). PfRab5bQ94L-YFP-DD positive 
TVN loops were mobile, while the PVM was immobile 
(Fig.  2a, b) the same as recently reported in P. berghei 
[54]. A parasite cytosolic marker, Plasmodium 2-Cys per-
oxiredoxin (PfTPx-1, PF14_0368) [43], was not detected 
from the PfRab5bQ94L-YFP-DD positive TVN loops, 
indicating that a portion of PfRab5bQ94L-YFP-DD local-
ized outside of the parasite (Fig. 2c). These observations 
suggest that PfRab5bQ94L-YFP-DD was secreted from the 
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parasite cytoplasm to the PV space and/or potentially to 
the RBC-cytoplasmic face of the PVM.
Second, the accessibility of antibodies after permeabili-
zation with different detergents was examined to evaluate 
the location of constitutively active PfRab5bQ94L proteins. 
iRBCs were treated with saponin, which permeabilizes 
the iRBC membrane and the PVM but not the parasite 
plasma membrane (Fig. 3a, SAP), and then PfRab5bQ94L-
YFP-DD was stained with anti-GFP antibody [55]. 
PfRab5bQ94L-YFP-DD, transported to outside of parasite, 
was detected by an anti-GFP antibody after the sapo-
nin lysis as punctate structures, only at the peripheral 
region of the parasite, but not in the parasite cytoplasm, 
among 20  % of PfRab5bQ94L-YFP-DD positive parasites, 
whereas YFP fluorescence was detected in the cytosol of 
all PfRab5bQ94L-YFP-DD parasite cytosol (Fig.  3b, SAP). 
These results indicat that secreted PfRab5bQ94L-YFP-DD 
at the periphery was recognized by anti-GFP antibody 
after treatment with saponin. In contrast, after permea-
bilization of the parasite plasma membrane with Triton 
X-100 (Fig.  3a, Triton), parasite cytosolic PfRab5bQ94L-
YFP-DD was detected with anti-GFP antibody (Fig.  3b, 
Triton). These results again indicate that a portion of 
PfRab5bQ94L-YFP-DD localized outside of the parasite 
plasma membrane.
Third, PfRab5bQ94L-YFP-DD protein that localizes to 
the parasite cytosol is considered to be degraded by the 
parasite proteasome pathway in the absence of Shld1 
[51]. Because of the weak proteasome activity in RBCs 
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Fig. 2 Localization of PfRab5bQ94L‑YFP‑DD to the TVN. a Time‑lapse imaging of PfRab5bQ94L‑YFP‑DD (green) and TR‑ceramide (red) fluorescence 
after stabilization with Shld1. PfRab5bQ94L‑YFP‑DD and TR‑ceramide was co‑localized to a rapidly moving compartment (arrowheads). b The pseu‑
docolours of TR‑ceramide at 0, 100, and 200 s in Fig. 2a were converted to red, green and blue, respectively, and then merged into a single frame. 
Several extended, mobile TVNs are shown in each colour (arrowhead as an example), whereas a stable PVM is shown in white. (c) Cells expressing 
PfRab5bQ94L‑YFP‑DD (green) were stained with anti‑PfTPx‑1 antibody (red) and DAPI (blue). Cytoplasmic PfTPx‑1 was not detected from the TVN, 
where PfRab5bQ94L‑YFP‑DD (arrowheads) localizes. Bars 5 µm
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negligible. Thus, PfRab5bQ94L-YFP-DD located inside of 
intracellular organelles or outside of the parasite cyto-
plasm would remain intact and YFP fluorescence would 
be apparent (Fig.  3c) [52]. To evaluate this hypothesis, 
the alteration of PfRab5bQ94L-YFP-DD localization was 
assessed after a 24-h incubation with Shld1 followed by 
2  h of incubation without Shld1. After this procedure, 
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and only punctate structures in the parasite cytoplasm 
and periphery were detected (16 % of PfRab5bQ94L-YFP-
DD positive parasites displayed a peripheral YFP signal, 
n = 42), suggesting that PfRab5bQ94L-YFP-DD was com-
partmentalized in the punctate structure in the cyto-
plasm and at the periphery of the PVM (Fig.  3d). The 
Amount of induced protein was decreased to 19 ± 4.1 % 
after the washout of Shld1 for 2  h compared to protein 
levels after 24 h incubation with Shld1 (Additional file 5e, 
f ). To further determine whether the peripheral dots of 
PfRab5bQ94L-YFP-DD localized inside of the PV or on the 
RBC-cytoplasmic face of the PVM, iRBCs were treated 
with SLO, which permeabilized the iRBC plasma mem-
brane but not the PVM or the parasite plasma membrane 
[55] (Fig.  3c, SLO), and then treated with a proteolytic 
enzyme proteinase K. Parasites expressing PfRab5bQ94L-
YFP-DD were incubated with Shld1 for 24  h, followed 
by incubation without Shld1 for 2  h (Fig.  3d, washout), 
and then subjected to immunoblotting after SLO-treat-
ment with or without proteinase K (Fig. 3e). The reduc-
tion of the PfRab5bQ94L-YFP-DD signal by proteinase K 
treatment (56.3 ± 22.3 %, n = 3) was significantly greater 
than that of the control PVM marker, exported protein 
2 (PfEXP2) (115 ± 25.3 %, n = 3, p < 0.05 between YFP 
and EXP2) (Fig. 3e, f ). As a positive control for degraded 
proteins, Maurer’s cleft membrane protein, SBP1, was 
processed from a 48  kDa full length (Fig.  3e, arrow) to 
37 kDa luminal domain (Fig. 3e, arrowhead) of Maurer’s 
cleft [58]. These results indicate that PfRab5bQ94L-YFP-
DD localized to the surface of the PVM and TVN facing 
the RBC cytoplasm. Wild-type form of Rab5b construct, 
PfRab5b-YFP-DD, also showed same response to the 
Shld1 washout and proteinase K treatment (Additional 
file  6), indicating that PfRab5b-YFP-DD was also trans-
ported to the RBC-cytoplasmic face of PVM/TVN.
PfRab5b and N‑acylated PfAK2 share the same trafficking 
pathway to the TVN
To determine the localization of PfRab5b within the par-
asite, the transgenic parasite line, PfRab5b-YFP-DD, was 
double-stained with organelle marker proteins; PfBip 
(ER) [46], PfSec13 (ER exit site) [23], PfERD2 (Golgi) 
[46], PfVPS2 (putative multivesicular body/endosome) 
[59, 60], FabHleader-RFP (apicoplast) [41], and PfTPx-2 
(mitochondria) [42]. Although PfRab5b-YFP-DD staining 
partially overlapped with PfBip staining, punctate YFP-
positive structures localized adjacent to the PfBip signal 
(Fig. 4a, arrowheads). All other marker proteins did not 
co-localize with PfRab5b-YFP-DD (Fig. 4b–f). These data 
suggest that PfRab5b associated with a compartment 
close to the ER, presumably at the initial step of mem-
brane trafficking.
Adenylate kinase 2 (PfAK2, PF08_0062) is an N-ter-
minally myristoylated and palmitoylated protein that 
is transported to the PVN and TVN [12, 13]. PfAK2 
does not possess a canonical PEXEL motif and N-ter-
minal acylation is essential for PfAK2 to pass through 
the parasite plasma membrane [13]. The N-terminally 
myristoylated and palmitoylated modification was also 
essential for the membrane association of PfRab5b [27], 
and transport to the TVM (Additional file  6). In mam-
malian cells, over-expression of Rab5 proteins stimulated 
aggregation on the membrane and affected trafficking of 
the cargo protein [18, 61]. To test whether PfAK2 shares 
the same trafficking pathway with PfRab5b, full-length 
PfAK2 fused to RFP (PfAK2-RFP) was co-expressed with 
PfRab5b-YFP-DD. In the absence of Shld1, PfRab5b-YFP 
signal was not detected at all, and PfAK2-RFP localized 
at the parasite periphery and TVN (Fig.  5a, −Shld1). 
After 48  h of incubation with Shld1, PfAK2-RFP signal 
was detected at the parasite periphery and the TVN in 
(See figure on previous page.) 
Fig. 3 Transport of PfRab5bQ94L‑YFP‑DD to the cytoplasmic face of infected red blood cells on the TVN. a The selective permeabilization scheme. 
Saponin permeabilizes RBC plasma membrane (RPM) and PVM, which allows the detection of proteins localized to the outside of the parasite plasma 
membrane (PPM) or both sides of the PVM. Triton X‑100 permeabilizes RPM, PVM, and PPM, allowing staining of the iRBCs, PV, and parasite cytosol 
with antibody. b Cells expressing PfRab5bQ94L‑YFP‑DD (green) were subjected to an antibody accessibility assay with anti‑GFP antibody (red) prior 
to permeabilization with saponin (upper panel, SAP) or Triton X‑100 (lower panel, Triton). After the saponin treatment, anti‑GFP antibody labelled 
PfRab5bQ94L‑YFP‑DD secreted to the TVN (arrowhead), whereas PfRab5bQ94L‑YFP‑DD in the parasite cytosol was not labelled. Permeabilization with 
Triton X‑100 allowed labelling of both the parasite cytosolic and TVN‑localized PfRab5bQ94L‑YFP‑DD with anti‑GFP antibody. c Schematic of the Shld1 
washout assay and the protease accessibility assay. After removal of Shld1, cytosolic DD‑tagged proteins are degraded (red cross and blue circle) by 
the parasite proteasome (yellow cylinder). DD‑tagged proteins, inside of intracellular organelles or transported to the outside of the parasite (blue 
circular), are resistant to the proteasomal degradation. Since streptolysin O (SLO) permeabilizes RPM but not PVM, DD‑tagged proteins in the RBC 
cytoplasm were selectively degraded by extracellular proteinase K (ProK) after permeabilization with SLO (black cross and blue circle). d Sub‑cellular 
localization of PfRab5bQ94L‑YFP‑DD (green) after Shld1 stabilization for 24 h (upper panel, Shld1) and 2 h after Shld1 washout (lower panel, washout). 
After the removal of Shld1, the punctate signal of PfRab5bQ94L‑YFP‑DD localized to the TR‑ceramide (red)‑labelled parasite periphery. Bars 5 µm. 
e Parasites expressing PfRab5bQ94L‑YFP‑DD were subjected to Shld1 washout after stabilization (Fig. 3d), and then permeabilized with SLO before 
treatment with proteinase K. Anti‑PfEXP2 and anti‑TPx‑1 antibodies were used as a control which is not processed with proteinase K, and a loading 
control for immunoblot analysis, respectively. Representative image from three independent experiments is shown. f The intensity of each band 
in Fig. 3e were quantitated and the intensity of the band with ProK (+) was divided by that of ProK(−) band. Significance was evaluated by the 
Student’s t test. Bars standard deviation (n = 3)





































Fig. 4 Localization of PfRab5b to a punctate compartment in the parasite cytoplasm. Triple staining with PfRab5b‑YFP‑DD (green), DAPI (blue) and 
one of the following markers (red): PfBip (a, ER), PfSec13‑RFP (b, ER exit site), PfERD2 (c, Golgi), PfVPS2‑RFP (d, putative multivesicular body/endo‑
some), FabHleader‑RFP (e, apicoplast), or PfTPx‑2 (f, mitochondria) after 24 h incubation with Shld1. PfRab5b‑YFP‑DD localized adjacent to the Bip 
signal (arrowheads). Bars 5 µm
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77  % of PfRab5b-YFP-positive parasites. In addition, 
a punctate profile, which appeared to be aggregated 
PfRab5b-YFP and PfAK2-RFP signals, was found in the 
parasite cytoplasm in 23 % of PfRab5b-YFP-positive par-
asites, suggesting that PfRab5b-YFP-DD and PfAK2-RFP 
were compartmentalized in the same punctate structure 
(Fig.  5a, middle, arrowheads in +Shld1). Compartmen-
talized PfAK2-RFP was still detectable even after 1 h of 
Shld1 washout (Fig. 5a, lower, washout). The ratio of the 
compartmentalized PfAK2-RFP increased with time after 
exposure to Shld1 [0 h: 0 % (n = 18), 6 h: 0 % (n = 15), 
24 h: 3.7% (n = 27), and 48 h: 23.1 % (n = 26)] (Fig. 5b). 
When PfAK2-RFP was co-expressed with the YFP-
DD protein fused to the N-terminal 20 aa of PfRab5b 
(PfRab5bN20-YFP-DD), which lacked the functional 
GTPase domain, the PfAK2-RFP positive punctate was 
not detected in the parasite cytoplasm (Fig. 5c), indicat-
ing that the GTPase activity of PfRab5b is required for 
the accumulation of PfAK2-RFP in vesicles or membra-
nous structure within the parasite.
These data suggest that the over-expression of func-
tional PfRab5b increased PfRab5b-mediated mem-
brane fusion, which, in turn, induced the aggregation of 
N-acylated PfAK2. To determine whether PfRab5b also 
participates in the trafficking of other exported proteins, 
the localization of non-N-acylated proteins, PfEVP1 
(a predicted PEXEL-positive transmembrane protein), 
PfSBP1 (a PEXEL-negative transmembrane protein), and 
the PVM marker protein PfEXP2, were also examined. In 
contrast to PfAK2-RFP, these proteins did not accumu-
late in the PfRab5b-YFP-DD and PfAK2-RFP-positive 
compartments within the parasite (Fig.  5d). The result 
suggest that their export to the iRBC cytoplasm was 
dependent on PfRab5b, and that PfRab5b plays a specific 
role in the export of N-acylated proteins to the TVN.
Discussion
Here, this study showed that Rab5b was essential for 
Plasmodium growth and that Rab5a and Rab5c did 
not complement Rab5b in P. berghei, confirming a pre-
vious report [27]. The constitutively active PfRab5b 
mutant was secreted into the PVM and TVN in iRBCs 
and localized on the RBC-cytoplasmic face of these 
membranes. Induced over-expression of PfRab5b by 
DD system resulted in the accumulation of N-acylated 
PfAK2 in the PfRab5b-positive compartment within 
the parasite, suggesting that the PfAK2 shares a traf-
ficking pathway which is Rab5b dependent. Analysis 
of the transport of other N-acylated proteins, such as 
PfCDPK1 [62, 63], will be required to further define the 
Rab5b-dependent pathway. Plasmodium falciparum 
secretes hundreds of proteins into RBC cytoplasm, most 
of which are transported through the PVM-localized 
translocon PTEX [1, 4]. In contrast to PfAK2, the trans-
port of non-N-acylated proteins, EVP1 and SBP1, which 
are expected to utilize PTEX, was not perturbed by the 
over-expression of PfRab5b. These results suggest the 
presence of a specific trafficking pathway for N-acylated 
proteins and Rab5b.
Hypothetical model of the transport of PfRab5b 
from parasites to the TVN
Although not all steps are experimentally validated, a 
proposed model consistent with this observations of 
PfRab5b-mediated transport of N-acylated proteins 
from the parasite to the RBC cytoplasm was shown 
(Fig. 6). The elements of the model are as follows: Step 
1: N-acylated proteins, including PfRab5b and PfAK2, 
are recruited to a novel compartment, either close to or 
within the ER, where they are anchored tightly to the 
membrane after their N-terminal Gly and Cys residues 
are myristoylated and palmitoylated, respectively. The 
existence of this step is supported by the adjacent locali-
zations of PfRab5b-YFP-DD and the ER marker PfBip 
(Fig.  4a). Step 2: N-acylated proteins on the vesicles 
that are released from the ER generate a multivesicular 
body (MVB), which lacks VPS2 or an autophagosome-
like double membrane structure together with PfRab5b, 
and N-acylated cargo proteins are internalized in the 
internal vesicles. The existence of this step is supported 
by the presence of residual PfRab5b-YFP-DD within 
the parasite after the removal of Shld1 (Figs.  3d, 5a). 
Over-expression of PfRab5b induced the accumulation 
of PfAK2 in this compartment (Fig. 5a), suggesting that 
(See figure on previous page.)  
Fig. 5 PfRab5b expression disturbed the transport of PfAK2 to the TVN. a In the absence of Shld1, PfAK2‑RFP (red) localized to the TVN, while 
PfRab5b‑YFP‑DD signal was not detect (−Shld1, upper panel). After Shld1 stabilization for 48 h, PfRab5b‑YFP‑DD (green) and PfAK2‑RFP co‑localized 
in the TVN‑like structures (+Shld1, middle-upper panel). In 77 % of PfRab5b‑YFP‑DD‑positive parasites, PfAK2‑RFP localized to the TVN, while in 23 % 
of PfRab5b‑YFP‑DD positive parasites, PfAK2‑RFP signals also accumulated in the punctate compartment within the parasite (+Shld1, middle-lower 
panel, arrowhead). Co‑localization of PfRab5b‑YFP‑DD and PfAK2‑RFP at the punctate compartment remained even after removal of Shld1 (washout, 
lower panel, arrowhead). b The bar graph showing the localization pattern of PfAK2‑RFP at 0, 6, 24, and 48 h after Shld1 treatment. c No punctate 
localization of PfAK2‑RFP was apparent with co‑expression of PfRab5bN20‑YFP‑DD. d Effect of PfRab5b over‑expression on the exported proteins 
PfSBP1, PfEVP1, and PfEXP2. In contrast to PfAK2‑RFP, these proteins did not accumulate in the PfRab5b‑ and PfAK2‑double positive punctate com‑
partments (arrowhead)
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PfRab5b positively regulates this step (Fig.  6, red box). 
Step 3: The PfRab5b-positive vesicle fuses with the para-
site plasma membrane in a PfRab5b-dependent manner 
and releases internal vesicles that contain PfRab5b and 
cargo proteins into the PV space. This step is proposed 
based on the mechanism for ARA6/RabF1-dependent 
vesicle trafficking in Arabidopsis [32]. Step 4: Cargo 
proteins released into the PV space fuse with the PVM 
and supply membrane components to newly gener-
ated PVM and TVN in iRBCs, and N-acylated proteins 
enter the iRBC cytoplasm. This process is supported by 
the detection of PfRab5b on the RBC cytoplasmic face 
of the PVM- and TVN (Figs.  2, 3). Step 5: PVM lipid 
compositions might be heterogeneous and form a spe-
cific lipid domain within the PVM where N-acylated 
proteins cluster (Fig.  6) [12]. Such membrane domain 
is consistent with a reported detergent-resistant mem-
brane fraction where palmitoylated proteins accumulate 
[12, 64, 65].
The palmitoylation motif is required for the PfRab5b 
transport to the RBC cytoplasm
When myristoylation or palmitoylation sites at Gly 
and Cys, respectively, were disrupted, both membrane 
recruitment [27] and secretion of PfRab5b to the PV 
(Additional file  6) were inhibited, indicating that either 
myristoylation or palmitoylation are required for trans-
port of PfRab5b beyond the parasite plasma mem-
brane. Specifically, the partial patch-like accumulation 
of PfRab5bC3A-YFP-DD in the parasite cytoplasm after 
the removal of Shld1 resembles that of the PfAK2C4A 
mutant, in which the palmitoylation site is altered [13]. 
The membrane structures where PfRab5C3A-YFP-DD 
and PfAK2C4A accumulate might be novel compartments 
where N-acylated proteins are selectively recognized 
and packed. Contiguous localization of PfRab5b-YFP-
DD with an ER marker suggests that palmitoylation of 
Rab5b occurs in the proximal region of the ER (Fig.  4). 
























Fig. 6 The hypothetical model of trafficking pathway involved in PfRab5b. N‑acylated proteins, such as PfAK2, are recruited to novel 
compartment(s) adjacent to the ER, and packed into the multivesicular body or an autophagosome‑like double membrane structure together with 
PfRab5b. The multivesicular body fuses with the PPM, and internal vesicles fuses with the PVM. Rab5b is clustered on the TVN. Nuc, nucleus; RBC, red 
blood cell; PTEX, Plasmodium translocon of exported proteins; PAT, palmitoyltransferase. EVP1 and SBP1 are exported proteins with and without the 
Plasmodium export element (PEXEL) signal, respectively
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the disruption of the palmitoylation site in ARA6/RabF1 
resulted in the change of its localization from endosomes 
to the ER [28].
Palmitoylation of proteins is regulated by a family of 
Asp-His-His-Cys (DHHC) motif-containing multi-trans-
membrane proteins, and P. falciparum and Toxoplasma 
gondii possess 12 and 18 members of this protein fam-
ily, respectively [66, 67]. Each protein with a DHHC motif 
exhibits a distinct localization and target protein specific-
ity, therefore, an ER-localized member is a prime candi-
date for palmitoylation of PfRab5b and cargo proteins in 
this pathway. PbDHHC5 and PbDHHC8 are good candi-
dates because they localize to a compartment close to the 
ER and unidentified vesicles, respectively [67]. Although 
it is tempting to speculate that a palmitoylation-depal-
mitoylation cycle may occur in the iRBC cytoplasm to 
facilitate vesicle trafficking of the parasite in the iRBC 
cytoplasm, further studies are required to assess this 
possibility.
Accumulation of PfRab5b on the PVM and TVM
Clustering of N-acylated proteins, including PfRab5b, 
within the TVN (Figs.  2c, 3b) indicates the presence of 
a specific membrane sub-domain stained with TR-cera-
mide in the TVN. The cholesterol-rich, detergent-resist-
ant, membrane domain (DRM) is a candidate membrane 
sub-domain where N-acylated proteins are preferentially 
localized in other organisms [11, 64]. PTEX is reported 
to form dot-like structures on the PVM, indicating the 
presence of hotspots of protein translocation to the RBC 
cytoplasm in P. falciparum [68] and in P. berghei [54] and 
PTEX components were identified in the DRM fraction 
from P. falciparum iRBCs [69]. However, PfAK2 and 
PfRab5b were not detected in this DRM fraction by the 
same analysis [69]. The identification of the extracellu-
lar membrane domain where PfAK2 and PfRab5b were 
detected needs further investigation. Identification of 
Rab5b effector proteins would stimulate the understand-
ing of this PfRab5b-regulated trafficking pathway.
Evolution of the PfRab5b‑dependent transport pathway
From an evolutionary perspective, the Rab5 family is 
divided into Rab5 and Rab22 subgroups [70]. The diver-
gence of the Rab5 and Rab22 subgroups likely occurred 
early in the evolution of eukaryotes, and Rab5 and Rab22 
sub-groups regulate different transport pathways in 
mammalian cells [71]. Both subgroups are widely con-
served among eukaryotes, including land plants and Api-
complexa [70]. In plants and Apicomplexa, conventional 
C-terminally isoprenylated Rab5 and N-terminal acylated 
Rab5 belong to the Rab5 and Rab22 sub-groups, respec-
tively [70]. These findings support the conclusion that the 
N-terminal acylated Rab5 family, e.g., plant ARA6/RabF1 
and apicomplexan Rab5b, mediates transport pathways 
that are distinct from those of conventional Rab5 [32, 
33, 53]. Together with the data provided in this study, 
it is reasonable to conclude that apicomplexan Rab5b 
was evolved to regulate protein transport to the PVM. 
Consistent with this idea, Babesia and Theileria, other 
apicomplexan parasite closely related to Plasmodium, 
possess neither PV nor Rab5b [72, 73]. The observa-
tion that TgRab5b did not complement PbRab5b func-
tion (Fig.  1d), may suggest species-specific interaction 
of Rab5b with its effector proteins, which needs future 
investigation. Furthermore, Rab5b-type Rab GTPases 
are conserved in the related Alveolata protozoan Perk-
insus [34, 70]. Further analysis of Rab5b in other living 
organisms, such as Toxoplasma, more distantly related 
protozoa that belongs to Superphylum Alveolata (such 
as Perkinsus) and plants will illuminate the importance of 
PfRab5b in the evolution of membrane trafficking.
Conclusions
N-myristoylated Plasmodium Rab5b plays a role that is 
distinct from that of conventional C-terminal isopreny-
laed Rab5 isotypes, Rab5a and Rab5c. PfRab5b localizes 
to a compartment close to the ER, translocated to the 
lumen of the organelle, and co-localizes with N-myris-
toylated protein, PfAK2. PfRab5b and PfAK2 are then 
transported to the TVN, and PfRab5b localizes on the 
iRBC cytoplasmic face of TVN. These data demonstrate 
that N-myristoylated proteins, PfRab5b and PfAK2, share 
the uncharacterized trafficking pathway to PVM.
Additional files
Additional file 1. Structures of constructs used in this study. Plasmids 
used for the analysis of P. berghei (a) or P. falciparum (b). For coexpression 
of PbRab5b‑mAG and RFP, a fusion fragment comprising the promoter 
region of the gene encoding the P. falciparum chloroquine resistance 
transporter (CRT) promoter [1], TagRFP amplified from the pTagRFP‑C 
plasmid (Evrogen), and PbDT were PCR‑amplified using overlapping 
oligonucleotides, and the In Fusion HD cloning kit was used to insert the 
DNA fragment into the XhoI site of the PbRab5b‑mAG plasmid (PbRab5b‑
mAG+RFP). For single crossover transfection of constitutive active PbRab‑
5bQ91L mutant, an upstream sequence encompassing nucleotide posi‑
tions at –1,500 bp to –500 bp of PbRab5b was inserted into HindIII site of 
the plasmid for double crossover (PbRab5bQ91L‑mAG for single crossover). 
Construction of PbRab5b‑mAG, PbRab5b Chimeric, GOI‑YFP‑DD, RFP, 
GOI‑RFP was described in the Materials section of the main manuscript.
Reference[1] van Dooren GG, Marti M, Tonkin CJ, Stimmler LM, Cowman 
AF, McFadden GI. (2005) Development of the endoplasmic reticulum, 
mitochondrion and apicoplast during the asexual life cycle of Plasmodium 
falciparum. Mol Microbiol; 57:405‑19.
Additional file 2: Table S1. List of oligonucleotide sequences used for 
plasmid construction.
Additional file 3. Multiple‑alignment of amino acids sequences of Plas-
modium Rab5b and Toxoplasma Rab5b. The GTP‑binding box (red boxes) 
and the effector domain (light green box) are shown. Amino acids in the 
blue box indicate N‑terminal myristoyl and palmitoyl modification sites. 
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Abbreviations
PEXEL: Plasmodium export element; PVM: parasitophorous vacuole mem‑
brane; PTEX: Plasmodium translocon of exported proteins; PVM: parasito‑
phorous vacuole membrane; TVN: tubovesicular network; PfAK2: Plasmodium 
falciparum adenylate kinase 2; GTPases: guanosine‑5′‑triphosphatases; DD: 
destabilization domain; mAG: Monomeric Azami Green; ORFs: open reading 
frames; PbDT: Plasmodium berghei dihydrofolate reductase; GOI: gene‑
of‑interest; SLO: streptolysin O; CRT: Plasmodium falciparum chloroquine 
resistance transporter; DHFR: dihydrofolate reductase; PFA: paraformaldehyde; 
PBS: phosphate‑buffered saline; PMSF: phenylmethylsulfonyl fluoride; BSD: 
blasticidin S.
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Additional file 4. Peripheral localization of PbRab5b‑mAG in tropho‑
zoite stage of parasites. (a) Fluorescence image of PbRab5b‑mAG in 
trophozoite‑stage parasites. Transgenic parasites expressing PbRab5b‑
mAG under the regulation of PbRab5b promoter were fixed with PFA, and 
faint cytosolic fluorescence of mAG were detected (green). Nuclei were 
stained with DAPI (blue). In control wild‑type parasites, mAG fluorescence 
signal was not detected. Bar, 10 μm. (b) Magnified images of trophozoites 
expressing both PbRab5b‑mAG and TagRFP. Trophozoite stage of parasites 
expressing PbRab5b‑mAG (green) and cytosolic TagRFP (red) were fixed 
and the mAG and TagRFP fluorescence signals were obtained. Histograms 
of the green and red intensities along the white arrow are shown in the 
right graph. Black arrowheads indicate regions where stronger PbRab5b‑
mAG signal were detected compared to the TagRFP signal. Bar, 5 μm. (c) 
Peripheral localization of PbRab5bQ91L‑mAG expressed under the regula‑
tion of PbRab5b promoter in trophozoite‑stage parasites. A constitutively 
active PbRab5bQ91L‑mAG mutant, in which Gln at aa 91 was replaced with 
Leu [1,2] was integrated into the upstream of PbRab5b genomic locus 
by single crossover method. Fluorescence of PbRab5bQ91L‑mAG mutant 
protein was accumulated at the periphery of the parasite (green). Nuclei 
were stained with DAPI (blue). Bar, 5 μm.References[1] Li G, Barbieri MA, 
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parasites expressing PfRab5b‑YFP‑DD (a) or PfRab5bQ94L‑YFP‑DD (b). 
Parasitemia (%) was measured after treatment with (green and yellow) or 
without (blue and red) 0.5 μM Shld1 in the presence of 5 nM WR99210‑
HCl. (c) Immunoblot using anti‑GFP antibody to probe PfRab5‑YFP‑DD 
showed that PfRab5‑YFP‑DD was highly expressed after the incubation 
with 0.5 μM of Shld1 for 24 h. Tpx1 is a loading control. (d) Quantification 
of intensity of PfRab5‑YFP‑DD in Additional Figure 5c. (e) Immunoblot of 
PfRab5‑YFP‑DD before or after washout of Shld1 for 2 h. (f ) Quantification 
of intensity of PfRab5‑YFP‑DD in Additional Figure 5e.
Additional file 6. N‑terminal myristoyl and palmitoyl modification of 
PfRab5b is essential for its transport to the TVN. (a) Subcellular localization 
of wild‑type and mutated PfRab5b‑YFP‑DD (green) after 24‑h Shld1 stabili‑
zation (left, Shld1) and after following 2‑h Shld1 washout (right, washout). 
The TR‑ceramide red fluorescent dye (red) labels the parasites and iRBC 
membranes. Washing out of Shld1 resulted in the loss of GFP signals from 
G2A and C3A mutants. (b) Immunoblotting after proteinase K (ProK) treat‑
ment of iRBCs permeabilized with streptolysin O. Anti‑PfEXP2 antibody is 
used as a control which is not processed with proteinase K.
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